Hi, what are you looking for?
– In the 9th March edition of Israel’s good news: ECONOMY & BUSINESS Please help us out : Will you offer us a hand?...
– Clal Biotechnology Industries Ltd. (TASE: CBI) has signed a non-binding letter of intent to sell diabetes treatment developer Andromeda Biotech Ltd. to a US pharmaceutical company for...
– – Eyal Ofer is the richest Israeli, with a fortune of $6.7 billion, followed by his brother, Idan Ofer, with a fortune of...
– Galmed Pharmaceuticals Ltd., a clinical-stage biotech developing therapies for liver diseases and gallstones, filed on Thursday with the SEC to raise up to $35...
– The burn and wound treatment company MediWound plans to raise $100m on Nasdaq at a $400 million valuation. – In the coming weeks, several Israeli...
– – Big Pharma is in trouble these days as the cost of researching and qualifying new drugs has risen rapidly, and in inverse...
– In the 2nd Feb 2014 edition of Israel’s good news: ECONOMY & BUSINESS Invest in the Innovation Nation. Prime Minister Benjamin Netanyahu was...
– In the 29th Dec 2013 edition of Israel’s good news: ECONOMY & BUSINESS Starting a business in Tel Aviv? Free consulting, marketing, legal...
– The Adverse Event Profile for Rolapitant was Consistent with Earlier Clinical Trials. Preparations Continue in Support of Submission of a New Drug Application...
– Some of the company’s Israeli shareholders having been cashing in on the share’s record price. – David Reis CEO Stratasys – The share...